Ocular Therapeutix
Price & Volume
Stats
See more52W Range | $5.78-$13.85 |
Market Cap | $2.1B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $56.6M |
Revenue Growth (YoY) | -18.1% |
Gross Profit (12 Mos) | -$121.3M |
Diluted EPS | -$1.26 |
News
See moreYahoo Finance • 1 hour ago
Ocular Therapeutix™ Investor Day to Highlight Exceptional AXPAXLI™ Progress Across SOL Program and Detail Registrational Trial Plans to Pursue a Diabetic Retinopathy Label with a Novel Primary Endpoint
Yahoo Finance • 24 days ago
Key deals this week: Ocular Therapeutix, CoreWeave, Air Lease, Cadence and more
Yahoo Finance • 2 months ago
Ocular gets FDA agreement for registrational trial of Axpaxl
Yahoo Finance • 2 months ago
Ocular Therapeutix secures FDA agreement for diabetic retinopathy trial
About
CEO | Dr. Pravin U. Dugel M.D. |
CFO | Mr. Donald Notman Jr. |
Address | 15 Crosby Drive, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 274 |
